Trupanion, Inc.

Equities

TRUP

US8982021060

Life & Health Insurance

Market Closed - Nasdaq 02:00:00 04/05/2024 am IST 5-day change 1st Jan Change
19.85 USD -16.53% Intraday chart for Trupanion, Inc. -17.70% -34.94%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
News Highlights : Top Financial Services News of the Day - Friday at 4 PM ET DJ
Trupanion Shares Drop After Q1 Results, New CEO Named MT
Transcript : Trupanion, Inc., Q1 2024 Earnings Call, May 02, 2024
Earnings Flash (TRUP) TRUPANION Posts Q1 Revenue $306.1M, vs. Street Est of $300.5M MT
Trupanion, Inc. Announces Chief Executive Officer Changes CI
Trupanion, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Trupanion Introduces truInsights: A Pet Health Data Initiative CI
Piper Sandler Cuts Price Target on Trupanion to $28 From $32, Maintains Overweight Rating MT
Daniel ?Dan? Levitan and Zay Satchu, Members of the Board of Directors Will Not Stand for Re-Election of Trupanion, Inc CI
Elanco Animal Health Appoints Two Ancora Holdings' Nominees to Board MT
Transcript : Trupanion, Inc. Presents at Bank of America Securities Financial Services Conference 2024, Feb-21-2024 02:30 PM
Sector Update: Financial Stocks Decline Late Afternoon MT
Sector Update: Financial Stocks Mixed in Afternoon Trading MT
Piper Sandler Trims Price Target on Trupanion to $32 From $33, Maintains Neutral Rating MT
Stifel Adjusts Price Target on Trupanion to $28 From $25, Maintains Hold Rating MT
Trupanion Preliminary Q4 Loss Narrows, Sales Rise; Shares Fall Pre-Bell MT
Wall Street Set to Open Mostly Lower Friday as Inflation Data Rises More Than Expected MT
Sector Update: Financial Stocks Decline Premarket Friday MT
Sector Update: Financial MT
Trupanion Preliminary Q4 Loss Narrows, Sales Rise; Shares Fall After-Hours MT
Trupanion Shares Fall 14% After Hours; Company Calls Q4 Results Preliminary as Assessment of Internal Controls Underway MT
Earnings Flash (TRUP) TRUPANION Reports Q4 Revenue $295.9M, vs. Street Est of $289.8M MT
Transcript : Trupanion, Inc., Q4 2023 Earnings Call, Feb 15, 2024
Trupanion, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Piper Sandler Adjusts Price Target on Trupanion to $33 From $28, Maintains Neutral Rating MT
Chart Trupanion, Inc.
More charts
Trupanion, Inc. is a provider of medical insurance for cats and dogs throughout the United States, Canada, Europe, Puerto Rico, and Australia. The Company operates in two segments: Subscription Business and Other Business. The Subscription Business segment includes subscription fees related to the Company's direct-to-consumer products. The Other Business segment comprises of other product offerings that generally have a business-to-business relationship and a different margin profile than its subscription segment, including writing policies on behalf of third parties and other products and software solutions. The Company’s core Trupanion product provides software that is designed to communicate directly with a veterinary hospitals practice management software. It provides Powered by Trupanion pet insurance product offerings marketed by third parties and, in Canada. The Company’s low and medium average revenue per unit (ARPU) products marketed under the brand Furkin and PHI Direct.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
19.85 USD
Average target price
32 USD
Spread / Average Target
+61.21%
Consensus
  1. Stock Market
  2. Equities
  3. TRUP Stock
  4. News Trupanion, Inc.
  5. Trupanion Acquires Smart Paws for Undisclosed Sum